1906 Continues Cannabis Reign East off the Rockies with Maryland Production and Distribution Partner Culta
August 25, 2020 at 8:53 pm Published by NCV Newswire
DENVER, CO. (August 25, 2020) — Leading cannabis brand 1906 has signed an agreement with Maryland single-state operator CULTA for production and distribution of its bestselling, fast-acting family of swallowable pills known as Drops. 1906’s arrival means Maryland patients will finally have access to low-dose, rapid-onset, cannabis in a non-combustible format. Drops’ pharma-grade pills range from 2.5-5mg of THC and 2.5-25mg of CBD per dose, carry no taste or aroma, have zero calories, and are gluten- and allergen-free. Available in six formulations, Drops address the most important and pervasive wellness needs of Maryland residents: sleep, anxiety, focus, energy, mood, and libido.
1906 will make its debut in medical dispensaries this fall, as the forward-looking company continues its quest to serve millions of patients and become the number one cannabis brand east of the Rockies.
With 92 registered dispensaries throughout the state, Maryland ranks among the highest in the nation in terms of medical marijuana dispensaries per capita, especially among states that have yet to legalize adult-use cannabis sales. There is also strong potential for the state to open up adult-use in the imminent future.
Founded in 2015 by some of Maryland’s most well known business and philanthropic families, CULTA wanted to create a Maryland-only, craft cannabis brand that not only focused on product quality, but also used cannabis as a tool for revitalization. Both 1906 and CULTA are deeply invested in changing the cultural narrative and societal perception surrounding the plant, are committed to the decriminalization of cannabis, and are proud supporters and contributors to The Last Prisoner Project.
By entering into a partnership with 1906, we are expanding our product offering to include best-in-class, effect-driven ingestibles in pill format. Maryland patients will have more options to consume their medicine backed by two trusted brands.
Maryland’s medical marijuana program has grown exponentially since operations and sales officially began in December 2017. To date, 1.6% of the total state population are registered medical-use patients, and June 2020 sales totaled $37.6 million, up more than 20% since January 2020. MJ Biz Daily shared that state sales hit $252 million in 2019, up from $109 million in 2018. Moreover, The Marijuana Business Factbook projects sales will roughly double this year to $425 -$525M, and reach $825M-$1B by 2024.
ABOUT 1906:
1906, a leader in self-care, is one of the most innovative brands in cannabis, creating groundbreaking functional formulations combining cannabis and plant medicines. 1906’s lineup delivers six unique experiences that promote sleep, energy, arousal, relaxation, cognitive focus, and a happy mood, all in consistently fast-acting formulations using organically-grown, pesticide-free cannabis. 1906 supports medicinal cannabis research and invests a percentage of its revenue in clinical trials and educating healthcare practitioners. The company also invests in corporate social responsibility, focusing on ending mass incarceration and creating employment opportunities for formerly incarcerated individuals who have paid the heaviest price for a century of cannabis prohibition.
For more information on 1906, please visit www.1906newhighs.com.
ABOUT CULTA:
Born in 2015, CULTA is Maryland’s premier craft quality producer of cannabis flower and cannabis extracts. We are proud and passionate cultivators, scientists, activists, musicians and global citizens. We believe in the power of cannabis to heal and for cannabis to be the catalyst to a long overdue conversation on ending the war on drugs. For many who have quietly battled chronic conditions with cannabis, it is more than a plant, it’s a medicine and lifestyle.
To learn more, please visit www.CULTA.io.
Source: 1906
August 25, 2020 at 8:53 pm Published by NCV Newswire
DENVER, CO. (August 25, 2020) — Leading cannabis brand 1906 has signed an agreement with Maryland single-state operator CULTA for production and distribution of its bestselling, fast-acting family of swallowable pills known as Drops. 1906’s arrival means Maryland patients will finally have access to low-dose, rapid-onset, cannabis in a non-combustible format. Drops’ pharma-grade pills range from 2.5-5mg of THC and 2.5-25mg of CBD per dose, carry no taste or aroma, have zero calories, and are gluten- and allergen-free. Available in six formulations, Drops address the most important and pervasive wellness needs of Maryland residents: sleep, anxiety, focus, energy, mood, and libido.
1906 will make its debut in medical dispensaries this fall, as the forward-looking company continues its quest to serve millions of patients and become the number one cannabis brand east of the Rockies.
With 92 registered dispensaries throughout the state, Maryland ranks among the highest in the nation in terms of medical marijuana dispensaries per capita, especially among states that have yet to legalize adult-use cannabis sales. There is also strong potential for the state to open up adult-use in the imminent future.
Founded in 2015 by some of Maryland’s most well known business and philanthropic families, CULTA wanted to create a Maryland-only, craft cannabis brand that not only focused on product quality, but also used cannabis as a tool for revitalization. Both 1906 and CULTA are deeply invested in changing the cultural narrative and societal perception surrounding the plant, are committed to the decriminalization of cannabis, and are proud supporters and contributors to The Last Prisoner Project.
By entering into a partnership with 1906, we are expanding our product offering to include best-in-class, effect-driven ingestibles in pill format. Maryland patients will have more options to consume their medicine backed by two trusted brands.
Maryland’s medical marijuana program has grown exponentially since operations and sales officially began in December 2017. To date, 1.6% of the total state population are registered medical-use patients, and June 2020 sales totaled $37.6 million, up more than 20% since January 2020. MJ Biz Daily shared that state sales hit $252 million in 2019, up from $109 million in 2018. Moreover, The Marijuana Business Factbook projects sales will roughly double this year to $425 -$525M, and reach $825M-$1B by 2024.
ABOUT 1906:
1906, a leader in self-care, is one of the most innovative brands in cannabis, creating groundbreaking functional formulations combining cannabis and plant medicines. 1906’s lineup delivers six unique experiences that promote sleep, energy, arousal, relaxation, cognitive focus, and a happy mood, all in consistently fast-acting formulations using organically-grown, pesticide-free cannabis. 1906 supports medicinal cannabis research and invests a percentage of its revenue in clinical trials and educating healthcare practitioners. The company also invests in corporate social responsibility, focusing on ending mass incarceration and creating employment opportunities for formerly incarcerated individuals who have paid the heaviest price for a century of cannabis prohibition.
For more information on 1906, please visit www.1906newhighs.com.
ABOUT CULTA:
Born in 2015, CULTA is Maryland’s premier craft quality producer of cannabis flower and cannabis extracts. We are proud and passionate cultivators, scientists, activists, musicians and global citizens. We believe in the power of cannabis to heal and for cannabis to be the catalyst to a long overdue conversation on ending the war on drugs. For many who have quietly battled chronic conditions with cannabis, it is more than a plant, it’s a medicine and lifestyle.
To learn more, please visit www.CULTA.io.
Source: 1906
1
